Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic
To reduce the spread of SARS-CoV-2, many pulmonary function testing (PFT) laboratories have been closed or have significantly reduced their testing capacity. Because these mitigation strategies may be necessary for the next 6 to 18 months to prevent recurrent peaks in disease prevalence, fewer objec...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12262
- Acceso en línea:
- https://www.sciencedirect.com/science/article/pii/S0012369220318675
http://hdl.handle.net/20.500.12010/12262
https://doi.org/10.1016/j.chest.2020.06.065
- Palabra clave:
- Pandemias
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Asthma
COPD
Pulmonary function test
Review
- Rights
- License
- Acceso restringido